Kathryn M Harper1, Darin J Knapp1,2, George R Breese1,2,3,4,5. 1. Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 2. Department of Psychiatry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 3. Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 4. Curriculum in Neurobiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 5. The UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Abstract
BACKGROUND: The role of neuroimmune activation in withdrawal from chronic alcohol (ethanol) has been established in both adolescent and adult models, but direct comparisons across age are sparse. Studies need to elucidate age-dependent neuroimmune effects of alcohol and to focus research attention on age-dependent mechanisms and outcomes. METHODS: Adult and adolescent rats from 2 commonly used strains, Wistar and Sprague Dawley (SD), were maintained on continuous 7%, 5.35%, 4.5% alcohol diet (CAD) or cycled 7% w/v alcohol diet for 15 days. Cortical tissue was collected at 0, 8, 16, and 24 hours postwithdrawal followed by measurement of chemokine (C-C motif) ligand 2 (CCL2), tumor necrosis factor alpha, and interleukin 1 beta mRNA with quantitative real-time polymerase chain reaction. RESULTS: Both age groups and strains showed a strong cytokine mRNA response at 7% CAD. Further, a greater increase in CCL2 mRNA was observed in the cortex of adolescents at 7% CAD, which correlated with higher blood alcohol levels (BALs). Adolescents exposed to 5.35% CAD exhibited similar blood levels and cytokine responses as adults exposed to 7% CAD. Substantial variability in CCL2 mRNA responses was found only in adolescent rats exposed to 7% CAD. In this group, data could be segregated into high-responding and low-responding groups. Moreover, the data from the high-responding group were associated with seizures. CONCLUSIONS: Relative to other cytokine mRNAs, CCL2 exhibits a unique response profile during withdrawal from CAD. This profile is shown in adolescents, where CCL2 is uniquely influenced by the effects of seizures. Additionally, this profile is shown by the fact that only CCL2 expression correlated with BAL that transcended age groups. These data emphasize the importance of BALs and treatment regimen on developmental neuroimmune responses and suggest that select components of the neuroimmune system are more responsive to CAD withdrawal and that neurobiological mechanisms differentiating these responses should be further explored.
BACKGROUND: The role of neuroimmune activation in withdrawal from chronic alcohol (ethanol) has been established in both adolescent and adult models, but direct comparisons across age are sparse. Studies need to elucidate age-dependent neuroimmune effects of alcohol and to focus research attention on age-dependent mechanisms and outcomes. METHODS: Adult and adolescent rats from 2 commonly used strains, Wistar and Sprague Dawley (SD), were maintained on continuous 7%, 5.35%, 4.5% alcohol diet (CAD) or cycled 7% w/v alcohol diet for 15 days. Cortical tissue was collected at 0, 8, 16, and 24 hours postwithdrawal followed by measurement of chemokine (C-C motif) ligand 2 (CCL2), tumor necrosis factor alpha, and interleukin 1 beta mRNA with quantitative real-time polymerase chain reaction. RESULTS: Both age groups and strains showed a strong cytokine mRNA response at 7% CAD. Further, a greater increase in CCL2 mRNA was observed in the cortex of adolescents at 7% CAD, which correlated with higher blood alcohol levels (BALs). Adolescents exposed to 5.35% CAD exhibited similar blood levels and cytokine responses as adults exposed to 7% CAD. Substantial variability in CCL2 mRNA responses was found only in adolescent rats exposed to 7% CAD. In this group, data could be segregated into high-responding and low-responding groups. Moreover, the data from the high-responding group were associated with seizures. CONCLUSIONS: Relative to other cytokine mRNAs, CCL2 exhibits a unique response profile during withdrawal from CAD. This profile is shown in adolescents, where CCL2 is uniquely influenced by the effects of seizures. Additionally, this profile is shown by the fact that only CCL2 expression correlated with BAL that transcended age groups. These data emphasize the importance of BALs and treatment regimen on developmental neuroimmune responses and suggest that select components of the neuroimmune system are more responsive to CAD withdrawal and that neurobiological mechanisms differentiating these responses should be further explored.
Authors: Jieun Choi; Douglas R Nordli; Tord D Alden; Arthur DiPatri; Linda Laux; Kent Kelley; Joshua Rosenow; Stephan U Schuele; Veena Rajaram; Sookyong Koh Journal: J Neuroinflammation Date: 2009-12-19 Impact factor: 8.322
Authors: Darin J Knapp; Buddy A Whitman; Tiffany A Wills; Robert A Angel; David H Overstreet; Hugh E Criswell; Zhen Ming; George R Breese Journal: Brain Behav Immun Date: 2011-03-04 Impact factor: 7.217
Authors: Céline M Dubé; Teresa Ravizza; Mark Hamamura; Qinqin Zha; Andrew Keebaugh; Kimberly Fok; Adrienne L Andres; Orhan Nalcioglu; Andre Obenaus; Annamaria Vezzani; Tallie Z Baram Journal: J Neurosci Date: 2010-06-02 Impact factor: 6.167
Authors: George R Breese; Darin J Knapp; David H Overstreet; Montserrat Navarro; Tiffany A Wills; Robert A Angel Journal: Neuropsychopharmacology Date: 2007-06-06 Impact factor: 7.853
Authors: Maira L Foresti; Gabriel M Arisi; Khurshed Katki; Andres Montañez; Russell M Sanchez; Lee A Shapiro Journal: J Neuroinflammation Date: 2009-12-24 Impact factor: 8.322
Authors: Kathryn M Harper; Darin J Knapp; Ryan K Butler; Cory A Cook; Hugh E Criswell; Garret D Stuber; George R Breese Journal: Alcohol Clin Exp Res Date: 2019-08-23 Impact factor: 3.455
Authors: Sudan Prasad Neupane; Andreas Skulberg; Knut Ragnvald Skulberg; Hans Christian D Aass; Jørgen G Bramness Journal: Mediators Inflamm Date: 2016-12-20 Impact factor: 4.711